These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9689831)

  • 1. Clinical efficacy and tolerance of nabumetone in articular and non-articular rheumatic disorders: personal experience during 12 weeks of treatment.
    Coaccioli S; Allegra A; Di Cato L; Puxeddu A
    Panminerva Med; 1998 Jun; 40(2):110-5. PubMed ID: 9689831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and efficacy of nabumetone and naproxen in the treatment of rheumatoid arthritis.
    Krug H; Broadwell LK; Berry M; DeLapp R; Palmer RH; Mahowald M
    Clin Ther; 2000 Jan; 22(1):40-52. PubMed ID: 10688389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of tolerability and efficacy of a nabumetone preparation in the treatment of patients with rheumatoid arthritis].
    Alianti M; Lotta C; Vaiani G
    Clin Ter; 1990 Jun; 133(5):299-308. PubMed ID: 2143713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of acute rheumatic-articular diseases with nabumetone].
    Riccieri V; Spadaro A; Iagnocco A
    Clin Ter; 1990 Aug 15-31; 134(3-4):181-5. PubMed ID: 2147618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients.
    Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Imbesi V
    Am J Gastroenterol; 1995 Sep; 90(9):1485-8. PubMed ID: 7661175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nabumetone compared with naproxen in the treatment of rheumatoid arthritis: a multicenter, double blind, randomized, parallel group trial in hospital outpatients.
    Emery P; Clarke A; Williams P; Kill D; Cree F; Redhead R; Poland M
    J Rheumatol Suppl; 1992 Nov; 36():41-7. PubMed ID: 1474534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerability of nabumetone in the treatment of painful symptomatology of rheumatoid arthritis and osteoarthrosis].
    Riccieri V; Spadaro A; Iagnocco A
    Clin Ter; 1991 May; 137(3):185-9. PubMed ID: 1831086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of rheumatic diseases with nabumetone. Results of a study using the drug in 18,046 patients].
    Lemmel EM; Stroehmann I
    Fortschr Med; 1988 Apr; 106(12):253-6. PubMed ID: 3260888
    [No Abstract]   [Full Text] [Related]  

  • 10. [Properties and features of nabumetone].
    Davies NM; McLachlan AJ
    Drugs; 2000; 59 Spec No 1():25-33. PubMed ID: 10841070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rationale for using nabumetone and clinical experience].
    Roth SH
    Drugs; 2000; 59 Spec No 1():35-41. PubMed ID: 10841071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the experience with nabumetone in clinical trials outside of the United States.
    Jenner PN; Johnson ES
    Am J Med; 1987 Oct; 83(4B):110-4. PubMed ID: 3318421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-blind comparative study of nabumetone (Relafen) versus naproxen in the treatment of rheumatoid arthritis.
    Hazleman BL; Thomas PP
    Am J Med; 1987 Oct; 83(4B):60-4. PubMed ID: 3318431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis.
    Roth SH
    Orthop Rev; 1992 Feb; 21(2):223-7. PubMed ID: 1538889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAIDs for the new decade--nabumetone?
    Huskisson EC
    Eur J Rheumatol Inflamm; 1991; 11(3):1-2. PubMed ID: 1365475
    [No Abstract]   [Full Text] [Related]  

  • 16. German drug monitoring studies with nabumetone.
    Stroehmann I; Fedder M; Zeidler H
    Drugs; 1990; 40 Suppl 5():38-42. PubMed ID: 2081491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin.
    Bernhard GC; Appelrouth DJ; Bankhurst AD; Biundo J; Bockow BI; Brobyn RD; Brodsky AL; Burch FX; Chang RW; Cohen MH
    Am J Med; 1987 Oct; 83(4B):44-9. PubMed ID: 3318428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroscopic evaluation of the effects of nabumetone on the gastrointestinal mucosa of rheumatic patients.
    Bianchi Porro G; Petrillo M; Ardizzone S; Caruso I; Montone F
    Eur J Rheumatol Inflamm; 1991; 11(3):38-42. PubMed ID: 1365479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of nabumetone in the treatment of active adult rheumatoid arthritis.
    Lanier BG; Turner RA; Collins RL; Senter RG
    Am J Med; 1987 Oct; 83(4B):40-3. PubMed ID: 3318427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.